S.African scientist: Data show J&J vaccine works well vs Delta variant
JOHANNESBURG — Data from laboratory studies show Johnson & Johnson’s COVID-19 vaccine works well against the Delta variant that now dominates new infections in South Africa, the head of the country’s Medical Research Council said on Friday.
“All the data that we see indicate good immediate and sustained immune response against Delta, and we see surprising durability in the immune response for the single dose J&J right up to eight months,” Glenda Gray told a news conference.
South Africa is using the J&J and Pfizer vaccines in its immunization campaign.
Subscribe to our daily newsletter
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.